[Retracted] Global increase in breast cancer incidence: risk factors and preventive measures

D Kashyap, D Pal, R Sharma, VK Garg… - BioMed research …, 2022 - Wiley Online Library
Breast cancer is a global cause for concern owing to its high incidence around the world.
The alarming increase in breast cancer cases emphasizes the management of disease at …

Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2

S Yadav, NJ Boddicker, J Na, EC Polley… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To estimate the risk of contralateral breast cancer (CBC) among women with
germline pathogenic variants (PVs) in ATM, BRCA1, BRCA2, CHEK2, and PALB2 …

Disparities in genetic testing and care among black women with hereditary breast cancer

S Reid, S Cadiz, T Pal - Current breast cancer reports, 2020 - Springer
Abstract Purpose of Review Despite a steady improvement in breast cancer survival rates
over the past several decades, mortality disparities remain among Black women, who have …

Risk of breast cancer among carriers of pathogenic variants in breast cancer predisposition genes varies by polygenic risk score

C Gao, EC Polley, SN Hart, H Huang, C Hu… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE This study assessed the joint association of pathogenic variants (PVs) in breast
cancer (BC) predisposition genes and polygenic risk scores (PRS) with BC in the general …

Evaluation of germline genetic testing criteria in a hospital-based series of women with breast cancer

S Yadav, C Hu, SN Hart, N Boddicker… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To determine the sensitivity and specificity of genetic testing criteria for the
detection of germline pathogenic variants in women with breast cancer. MATERIALS AND …

Germline pathogenic variants in cancer predisposition genes among women with invasive lobular carcinoma of the breast

S Yadav, C Hu, KL Nathanson, JN Weitzel… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To determine the contribution of germline pathogenic variants (PVs) in hereditary
cancer testing panel genes to invasive lobular carcinoma (ILC) of the breast. MATERIALS …

BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients

L Incorvaia, D Fanale, M Bono, V Calò… - Therapeutic …, 2020 - journals.sagepub.com
Background: Several available data suggest the association between specific molecular
subtypes and BRCA1/2 mutational status. Previous investigations showed the association …

Management of hormone receptor-positive, HER2-negative early breast cancer

EM Walsh, KL Smith, V Stearns - Seminars in oncology, 2020 - Elsevier
The majority of breast cancers are diagnosed at an early stage and are hormone receptor
(HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative. Significant …

Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes

L Incorvaia, D Fanale, G Badalamenti, M Bono, V Calò… - Cancers, 2020 - mdpi.com
Recent advances in the detection of germline pathogenic variants (PVs) in BRCA1/2 genes
have allowed a deeper understanding of the BRCA-related cancer risk. Several studies …

A primary luminal/HER2 negative breast cancer patient with mismatch repair deficiency

X Yang, A Smirnov, OC Buonomo, A Mauriello… - Cell Death …, 2023 - nature.com
Here, we present the case of a 47-year-old woman diagnosed with luminal B breast cancer
subtype and provide an in-depth analysis of her gene mutations, chromosomal alterations …